Latest Breaking News On - Cytomx therapeutics inc - Page 2 : comparemela.com

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

Cytomx Therapeutics To Present At The Jefferies Global Healthcare Conference

(MENAFN - GlobeNewsWire - Nasdaq) SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated . .

Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Price Target at $6.42

Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) have earned an average rating of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price […]

CytomX Therapeutics Announces New Employment Inducement Grants

Baystreet.ca - Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer